Recombinant multi-species NEDD4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NEDD4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is the founding member of the NEDD4 family of HECT ubiquitin ligases that function in the ubiquitin proteasome system of protein degradation. The encoded protein contains an N-terminal calcium and phospholipid binding C2 domain followed by multiple tryptophan-rich WW domains and, a C-terminal HECT ubiquitin ligase catalytic domain. It plays critical role in the regulation of a number of membrane receptors, endocytic machinery components and the tumor suppressor PTEN. [provided by RefSeq, Jul 2016]
The Alternative Names of target: NEDD4,E3 ubiquitin-protein ligase NEDD4,Cell proliferation-inducing gene 53 protein, HECT-type E3 ubiquitin transferase NEDD4, Neural precursor cell expressed developmentally down-regulated protein 4 (NEDD-4),RPF1,NEDD4-1
Go
to NEDD4 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T94980-Ab-1/ GM-Tg-hg-T94980-Ab-2 | Human NEDD4 protein | Human |
GM-Tg-rg-T94980-Ab-1/ GM-Tg-rg-T94980-Ab-2 | Rat NEDD4 protein | Rat |
GM-Tg-mg-T94980-Ab-1/ GM-Tg-mg-T94980-Ab-2 | Mouse NEDD4 protein | Mouse |
GM-Tg-cynog-T94980-Ab-1/ GM-Tg-cynog-T94980-Ab-2 | Cynomolgus/Rhesus macaque NEDD4 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T94980-Ab-1/ GM-Tg-felg-T94980-Ab-2 | Feline NEDD4 protein | Feline |
GM-Tg-cang-T94980-Ab-1/ GM-Tg-cang-T94980-Ab-2 | Canine NEDD4 protein | Canine |
GM-Tg-bovg-T94980-Ab-1/ GM-Tg-bovg-T94980-Ab-2 | Bovine NEDD4 protein | Bovine |
GM-Tg-equg-T94980-Ab-1/ GM-Tg-equg-T94980-Ab-2 | Equine NEDD4 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T94980-Ab-1/ GM-Tg-hg-T94980-Ab-2;
GM-Tg-rg-T94980-Ab-1/ GM-Tg-rg-T94980-Ab-2;
GM-Tg-mg-T94980-Ab-1/ GM-Tg-mg-T94980-Ab-2; GM-Tg-cynog-T94980-Ab-1/ GM-Tg-cynog-T94980-Ab-2; GM-Tg-felg-T94980-Ab-1/ GM-Tg-felg-T94980-Ab-2; GM-Tg-cang-T94980-Ab-1/ GM-Tg-cang-T94980-Ab-2; GM-Tg-bovg-T94980-Ab-1/ GM-Tg-bovg-T94980-Ab-2; GM-Tg-equg-T94980-Ab-1/ GM-Tg-equg-T94980-Ab-2 |
Products Name | NEDD4 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | NEDD4 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NEDD4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.